All In Biotech

Free tool

FAERS Monitor: Derma-Smoothe/Fs

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019452 or its brand name (Derma-Smoothe/Fs, Fluocinolone Acetonide). Reports on generic versions are filed under their own applications.

Reports

2,062

Serious

880

43% of reports

Hospitalization

315

Death reported

48

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective209
  • pruritus205
  • rash165
  • diarrhoea129
  • psoriasis125
  • headache113
  • off label use113
  • fatigue107
  • pain105
  • dermatitis atopic93
  • nausea93
  • dry skin80
  • product dose omission issue80
  • product use in unapproved indication78
  • arthralgia77

Reports by year received

View as table
YearReports
20048
200515
200610
200712
200818
200931
201020
201156
201257
201325
201437
201564
201687
201782
201889
2019125
2020132
2021131
2022175
2023223
2024201
2025248
2026216

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,097 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
dermatitis atopicSignal9318.014.81,479
psoriasisSignal1259.88.2981
dry skinSignal806.14.9339
pruritusSignal2055.44.8752
rashSignal1653.93.3354
product use in unapproved indicationSignal783.22.6118
product dose omission issueSignal802.82.290
diarrhoeaSignal1292.01.769
arthralgia771.91.532
headache1131.81.544
pain1051.71.434
drug ineffective2091.61.452
fatigue1071.41.212
off label use1131.31.19
nausea931.21.03

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.